Search

Search Results
Results 7271 - 7280 of 7292 for parkinson
  • Invega
    Drug - 11 Aug 2020
    Consumer Medicine Information (CMI) about Invega (Paliperidone) intended for persons living in Australia.
  • Ebixa
    Drug - 10 Jun 2020
    Consumer Medicine Information (CMI) about Ebixa (Memantine hydrochloride) intended for persons living in Australia.
  • Minims Atropine Sulphate
    Drug - 1 May 2020
    Consumer Medicine Information (CMI) about Minims Atropine Sulphate (Atropine sulfate monohydrate) intended for persons living in Australia.
  • Lamisil Tablets
    Drug - 13 Feb 2020
    Consumer Medicine Information (CMI) about Lamisil Tablets (terbinafine) intended for persons living in Australia.
  • Kytril Injection
    Drug - 19 Oct 2017
    Consumer Medicine Information (CMI) about Kytril Injection (granisetron hydrochloride) intended for persons living in Australia.
  • Kytril Tablets
    Drug - 19 Oct 2017
    Consumer Medicine Information (CMI) about Kytril Tablets (granisetron hydrochloride) intended for persons living in Australia.
  • Clopine
    Drug - 2 Jul 2024
    Consumer Medicine Information (CMI) about Clopine intended for persons living in Australia.
  • Clozaril
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Clozaril intended for persons living in Australia.
  • Sino Biological Inc.
    Supplier - 11 Mar 2021
    Sino Biological is an international reagent supplier and service provider. The company specializes in recombinant protein production and antibody development.
  • Alleo Labs Corp.
    Supplier - 15 Oct 2024
    We're developing new medicines for Alzheimer's and Parkinson's disease.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback